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Intraoperative embolization with poloxamer 407
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Surgical excision is the preferred definitive treatment for carotid body tumors, although postoperative morbidity rate as
quoted in the literature is rather high. Morbidity includes cranial nerve dysfunction, stroke, and the majority severe blood
loss. Embolization of the feeding branches of the external carotid artery can be performed a few days prior to surgery with
the intention to decrease blood loss during operation, facilitate surgical resection, and reduce operating time and
morbidity. The special risk of embolization is migration into the intracranial circulation. Poloxamer 407, a reverse-
thermal polymer, is a nontoxic compound that is a viscous liquid at room temperatures but instantly changes to a firm
water-soluble gel when warmed to body temperature. It dissolves spontaneously or can be dissolved at will by cooling. We
describe an intraoperative technique for complete devascularization of carotid body tumor by using an intraarterial
temporary occlusion technique with a poloxamer 407. (J Vasc Surg 2012;56:1782-5.)
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hCarotid body tumors (CBTs) are nonchromaffin para-
gangliomas of the carotid body. They are rarely malignant,
usually asymptomatic, and have generally been associated
with substantive procedural complications, mainly blood
loss.1 The benefits of preoperative embolization are a re-
duction in the technical difficulty of the procedure, reduced
operative time, reduced bleeding, reduced operative cranial
nerve morbidity and decreased length of hospital stay.2
The poloxamer 407 (LeGoo; Pluromed, Woburn, Mass)
is a thermosensitive nontoxic and nonthrombogenic polymer.
When it is introduced into a blood vessel at body temperature,
the viscous liquid injected transforms instantaneously into a
firm occlusive plug that conforms to the contour of the vessel
lumen. This conformational change to the somewhat linear
polymer allows it to form micelles, which cause an increase in
viscosity. It either dissolves spontaneously after 10 to 20
minutes in situ or can be dissolved at will by hand massage,
application of ice/cold saline over the surface of the vessel, or
use of an instrument that disrupts the physical integrity of the
firm gel. The polymer dissolves from its micellar form into
unimeric molecules and it is excreted in the urine.3 Vascular
occlusion with the use of polymer has previously been evalu-
ated for temporary artery occlusion during coronary artery
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1782ypass grafting and partial nephrectomy. In peripheral vascu-
ar surgery, it has achieved a satisfactory bloodless field in 92%
f anastomoses4 and amean occlusion time of 13.4minutes.5
We present this combined open surgical and endovas-
ular technique that used poloxamer 407 as a temporary
cclusion device during the surgical resection of a CBT.
ASE REPORT
An 81-year-old female patient presented with a carotid body
araganglioma, localized typically in the right extracranial carotid
ifurcation. The patient could feel and palpate the mass in her
eck, but there was no evidence of cranial nerve dysfunction. On
hysical examination, the patient had a nontender mass located
ust anterior to the sternocleidomastoid muscle. Duplex ultra-
onography scan was performed initially, demonstrating a hyper-
ascular mass located at and splaying the right carotid bifurcation.
agnetic resonance imaging revealed a well-defined heterogenous
ass at the region of the carotid bifurcation that exhibited intense
ontrast enhancement after intravenous administration of gadolin-
um. The tumor measured 3.2 cm  3.4 cm.
Surgical technique. The procedure was performed with the
atient under general anesthesia. After dissection of the common
arotid artery and liberalization of the hypoglossal nerve, a tran-
carotid approach was used to insert a 6F introducer (Fig 1, A and
). In cases with long external carotid artery (ECA) free of tumor,
he approach through ECA could be feasible. Angiography was
ccomplished under C-arm fluoroscopy (Fig 2, A), and an Insyte
ntravenous catheter (18GA 1.3mm 45mm, BectonDickinson,
ranklin Lakes, NJ) was advanced over a 0.035” angled tip wire
Radiofocus guide wire; Terumo Europe NV, Leuven, Belgium)
nto the ECA (Fig 2, B). One mL of poloxamer was injected by
and, and a localized gel polymer vascular plug of about 2 cm was
ormed in the arterial region immediately distal to the catheter tip.
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cularization (Fig 2, C). Surgery was performed using bipolar and
sharp dissection in a craniocaudal fashion. The dissection was done
in the subadventitial plane. Complete tumor removal was achieved
as en bloc removal and was easily performed (Fig 1, C and D).
Because of its invasiveness, this tumor was classified as Shamblin
type 2. Upon completion of the body tumor resection, the plug
was dissolved through the application of cold saline over the ECA
(Fig 2, D). Intraoperative blood loss was 115.2 mL, and operative
time was 78 minutes; no blood transfusions were necessary. The
specimen was sent to pathology. There were neither hemorragic
nor neurologic complications. The hospital stay was 4 days. Anal-
ysis of the specimen confirmed the presence of a paraganglioma of
the carotid body without evidence of malignancy. Follow-up at 6
months showed no morbidities.
DISCUSSION
Primary surgical excision is the preferred treatment for
the CBT. Endovascular preoperative embolization has
been proven to facilitate surgery due to elimination of
hypervascularity and tumor pulsation, facilitating surgical
tumor removal and diminishing the need for red blood cell
transfusions. The intraoperative blood loss range published
in patients with preoperative embolization varies from 20
to 1000 mL.6-7
Zeitler et al,6 in 2010, found no significant reduction in
intraoperative blood loss comparing 10 patients with pre-
operative embolization with 15 patients who underwent
excision without it. Nevertheless, a retrospective study
Fig 1. A, Common carotid artery injection showing a c
carotid artery (ECA). B, Advance of the 18G long abboc
tumor was devascularized. D, Arteriography after carotidpublished by Vogel et al2 with 2117 patients demonstrated ahat excision combined with preoperative embolization was
ore expensive but was associated with significantly fewer
omplications and decreased blood product utilization.
lso, transarterial embolization includes potential compli-
ations of stroke, with migration of the embolic material
nto the intracranial circulation via collaterals and cranial
erve palsies caused by edema secondary to nerve compres-
ion or migration of embolic material to the vasa nervosa.7
n addition, the act of embolization itself requires skilled
xpertise to perform these often long and tedious interven-
ions.
The direct percutaneous embolization with n-bytul-
yanoacrylate or Onyx has been described in cases with
ultiple small-caliber arterial feeders and in cases of incom-
lete devascularization following transarterial emboliza-
ion.7,8 Nevertheless, there are potential risks of acute
isplacement of glue into brain-supplying arteries during
njection, and even delayed migration has been described,8
o a balloon-protection technique has been described.9
Scanlon et al,10 in 2008, described three cases of CBTs
reated by interrupting vascular supply via covered stent
lacement in the ECAwith a follow-up range from 23 to 36
onths with neither strokes nor deaths but with some mild
ranial nerve dysfunction postoperatively.
This technique has numerous advantages over emboli-
ation, several of them shared with other procedures of
CA occlusion.10 Covering the branches of the ECA from
he origin to the level of the highest feeder artery also
xcludes any smaller, angiographically unseen vessels. In
d paraganglioma, with arterial supply from the external
to the ECA. C, Immediately after plug deployment, the
y tumor excision and poloxamer dissolution.aroti
ath inddition, there are usually several vessels feeding the tumor,
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positioning and careful delivery of embolization agents.
Also, the temporary occlusion with poloxamer is a one-step
technique, easy to develop, and totally reversible. So, in
case of migration of poloxamer into the cranial circulation,
the substance dilutes in a few minutes with no possibility of
Fig 2. A, Intraoperative exposure of the carotid body tu
C, En bloc tumor removal. D, The carotid bifurcation
cranial nerves and the external carotid artery (ECA).permanent occlusion. Also, it could never achieve the re- tuired concentration to change into a firm plug and origi-
ate cerebral infarction. However, it would be interesting
o confirm this alleged innocuity with imaging studies (eg,
agnetic resonance imaging, transcranial Doppler). It is
mpossible for the solution to form a gel when the concen-
ration is below 12.5%. The potential disadvantage is the
B, Poloxamer injection through common carotid access.
the excision of the tumor, showing preservation of themor.
afterime limitation, but after 10 to 20 minutes of surgical
1JOURNAL OF VASCULAR SURGERY
Volume 56, Number 6 San Norberto et al 1785resection, the poloxamer injection could be repeated. After
glomus resection, a secure maneuver is cooling the carotid
bifurcation with cold saline to be completely secure about
the poloxamer dissolution and eliminate the potential of
delayed bleeding. Another limitation is transarterial embo-
lization not leading to complete devascularization because
veins draining the tumor remain patent. Nevertheless, this
internal vessel occluder is approved by the Food and Drug
Administration exclusively for temporary endovascular oc-
clusion of blood vessels below the neck up to 4 mm in
diameter. This case represents an off-label use. It is also
important to point out that this mechanism of occlusion is
physiologically different from current approaches.
CONCLUSIONS
This case suggests that intraoperative embolization
with poloxamer 407 is an effective and safe adjunct proce-
dure for surgical resection of CBTs. This technique reduces
operative blood loss, makes for a less hazardous dissection,
eliminates the risk of embolization into the intracranial
circulation, and facilitates totally reversible arterial occlu-
sion. In our opinion, indications for this relatively simple
and less time-consuming technique can be extended to all
types of CBTs.
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